Resolvin E1 is a novel anti-inflammatory and anti-fibrotic lipid mediator for the treatment of chronic kidney desease.

Li, Jinhua (Primary Chief Investigator (PCI))
Nikolic-Paterson, David (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/10 → 31/12/12

Funding

National Health and Medical Research Council (NHMRC) (Australia): AUD499,250.00
National Health and Medical Research Council (NHMRC) (Australia): AUD99,850.00